Le Lézard
Classified in: Health, Business
Subject: CCA

Invesque Announces Details of Third Quarter 2020 Earnings Call


TORONTO, Oct. 19, 2020 /CNW/ - Invesque Inc. (the "Company") (TSX: IVQ.U) (TSX: IVQ) will release its fiscal 2020 third quarter results on Wednesday, November 11, 2020 after markets close. Management of the Company will hold a conference call at 10:00 a.m. ET on Thursday, November 12, 2020 to review the financial results.      

CONFERENCE CALL DETAILS:

DATE:

Thursday, November 12, 2020



TIME:

10:00 a.m. ET



DIAL IN NUMBER:

647-427-7450

1-888-231-8191



CONFERENCE ID:

5953538



WEBCAST:

Available at http://www.invesque.com/company-presentations/.
Please connect at least 15 minutes prior to the conference call
to ensure adequate time for any software download that may be
required to join the webcast. The webcast will be archived on
the Company's website following the call date.  



TAPED REPLAY:

416-849-0833 or 1-855-859-2056

Available from 12:45 p.m. ET on November 12, 2020 until 11:59
p.m. ET on November 19, 2020.



REFERENCE NUMBER:

5953538



ABOUT INVESQUE:      

Invesque is a North American health care real estate company with an investment thesis focused on the premise that an aging demographic in North America will continue to utilize health care services in growing proportion to the overall economy. Invesque currently capitalizes on this opportunity by investing in a highly diversified portfolio of income generating properties across the health care spectrum. Invesque's portfolio includes investments in independent living, assisted living, memory care, skilled nursing, transitional care and medical office properties, which are operated primarily under long-term leases and joint venture arrangements with industry leading operating partners. Invesque's portfolio also includes investments in owner-occupied seniors housing properties in which Invesque owns the real estate and provides management services through its subsidiary management company, Commonwealth Senior Living. For more information, please visit www.invesque.com.

SOURCE Invesque Inc.


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: